Article de revue
Effect of IPTi during infancy on serological responses to measles and other vaccines
Intermittent preventive treatment for malaria during infancy (IPTi) is the administration of a full therapeutic course of antimalarial drugs to infants living in settings where malaria is endemic, at the time of routine vaccination in the first year of life. The researchers investigated whether IPTi with sulfadoxine-pyrimethamine or other antimalarial drug combinations adversely affected serological responses to vaccines used in the Expanded Programme on Immunization (EPI). They concluded that IPTi with sulfadoxine-pyrimethamine does not affect serological responses to EPI vaccines. This analysis, therefore, supports the WHO recommendation for coadministration of IPTi with sulfadoxine-pyrimethamine to infants at the time of the second and third doses of DTP and measles vaccination, in areas of sub-Saharan Africa with moderate to high malaria transmission and where malaria parasites are sensitive to these drugs. It also suggests that treatment of clinical malaria at or around the time of vaccination does not compromise vaccine responsiveness.
Auteurs
Langues
- Anglais
Année de publication
2012
Journal
The Lancet
Volume
9846
Type
Article de revue
Catégories
- Prestation de services
Maladies
- Diphtérie
Pays
- Ghana
- Kenya
- Mozambique
Mots-clés
- Promotion de la santé
- Intégration
Régions de l'OMS
- Région africaine